ELAPRASE Trademark

Trademark Overview

On Thursday, September 8, 2005, a trademark application was filed for ELAPRASE with the United States Patent and Trademark Office. The USPTO has given the ELAPRASE trademark a serial number of 78709009. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, October 12, 2017. This trademark is owned by Transkaryotic Therapies, Inc.. The ELAPRASE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Hunter's syndrome
elaprase

General Information

Serial Number78709009
Word MarkELAPRASE
Filing DateThursday, September 8, 2005
Status800 - REGISTERED AND RENEWED
Status DateThursday, October 12, 2017
Registration Number3320424
Registration DateTuesday, October 23, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Hunter's syndrome

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 15, 2005
Primary Code005
First Use Anywhere DateMonday, July 31, 2006
First Use In Commerce DateMonday, July 31, 2006

Trademark Owner History

Party NameSHIRE HUMAN GENETIC THERAPIES, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameSHIRE HUMAN GENETIC THERAPIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameSHIRE HUMAN GENETIC THERAPIES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameTranskaryotic Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Trademark Events

Event DateEvent Description
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 12, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, October 12, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, October 12, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, October 12, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 12, 2017TEAS SECTION 8 & 9 RECEIVED
Sunday, October 23, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, February 14, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, February 14, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 14, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 1, 2013TEAS SECTION 8 & 15 RECEIVED
Thursday, June 30, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 30, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 8, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 8, 2009TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 23, 2007REGISTERED-PRINCIPAL REGISTER
Friday, September 14, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, September 14, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 31, 2007STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 15, 2007USE AMENDMENT FILED
Wednesday, August 15, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, June 5, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 13, 2007PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2007NOTICE OF PUBLICATION
Wednesday, January 24, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 24, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 5, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 5, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 5, 2007ASSIGNED TO LIE
Saturday, December 2, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 10, 2006LETTER OF SUSPENSION E-MAILED
Saturday, June 10, 2006SUSPENSION LETTER WRITTEN
Tuesday, May 16, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, May 7, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, May 7, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 21, 2006LETTER OF SUSPENSION E-MAILED
Tuesday, March 21, 2006SUSPENSION LETTER WRITTEN
Tuesday, March 21, 2006ASSIGNED TO EXAMINER
Tuesday, October 11, 2005PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, October 11, 2005TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, September 15, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

elaprase pharmaceutical treatment preparations syndrome hunter enzyme deficiencies